MIT researchers develop a molecular assay to detect sub-picomolar levels of the SARS-CoV-2’s receptor-binding domain

By | June 8, 2021
A team of researchers at MIT has developed a molecular assay to detect sub-picomolar levels of the SARS-CoV-2’s spike protein receptor-binding domain (S-RBD) using computationally validated peptide beacons in a single-step detection through the production of a fluorescence signal.